An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection - PubMed (original) (raw)
An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection
Peggy Han et al. J Immunol. 2004.
Abstract
Positive selection of developing thymocytes is associated with changes in cell function, at least in part caused by alterations in expression of cell surface proteins. Surprisingly, however, few such proteins have been identified. We have analyzed the pattern of gene expression during the early stages of murine thymocyte differentiation. These studies led to identification of a cell surface protein that is a useful marker of positive selection and is a likely regulator of mature lymphocyte and APC function. The protein is a member of the Ig superfamily and contains conserved tyrosine-based signaling motifs. The gene encoding this protein was independently isolated recently and termed B and T lymphocyte attenuator (Btla). We describe in this study anti-BTLA mAbs that demonstrate that the protein is expressed in the bone marrow and thymus on developing B and T cells, respectively. BTLA is also expressed by all mature lymphocytes, splenic macrophages, and mature, but not immature bone marrow-derived dendritic cells. Although mice deficient in BTLA do not show lymphocyte developmental defects, T cells from these animals are hyperresponsive to anti-CD3 Ab stimulation. Conversely, anti-BTLA Ab can inhibit T cell activation. These results implicate BTLA as a negative regulator of the activation and/or function of various hemopoietic cell types.
Similar articles
- B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells.
Hurchla MA, Sedy JR, Gavrieli M, Drake CG, Murphy TL, Murphy KM. Hurchla MA, et al. J Immunol. 2005 Mar 15;174(6):3377-85. doi: 10.4049/jimmunol.174.6.3377. J Immunol. 2005. PMID: 15749870 - Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice.
Ogilvy S, Louis-Dit-Sully C, Cooper J, Cassady RL, Alexander DR, Holmes N. Ogilvy S, et al. J Immunol. 2003 Aug 15;171(4):1792-800. doi: 10.4049/jimmunol.171.4.1792. J Immunol. 2003. PMID: 12902479 - Comparison of thymocyte development and cytokine production in CD7-deficient, CD28-deficient and CD7/CD28 double-deficient mice.
Heinly CS, Sempowski GD, Lee DM, Patel DD, McDermott PM, Scearce RM, Thompson CB, Haynes BF. Heinly CS, et al. Int Immunol. 2001 Feb;13(2):157-66. doi: 10.1093/intimm/13.2.157. Int Immunol. 2001. PMID: 11157849 - BTLA and HVEM cross talk regulates inhibition and costimulation.
Gavrieli M, Sedy J, Nelson CA, Murphy KM. Gavrieli M, et al. Adv Immunol. 2006;92:157-85. doi: 10.1016/S0065-2776(06)92004-5. Adv Immunol. 2006. PMID: 17145304 Review. - Antigen-presenting cells and T-lymphocytes homing to the thymus shape T cell development.
Santamaria J, Darrigues J, van Meerwijk JPM, Romagnoli P. Santamaria J, et al. Immunol Lett. 2018 Dec;204:9-15. doi: 10.1016/j.imlet.2018.10.003. Epub 2018 Oct 9. Immunol Lett. 2018. PMID: 30308217 Review.
Cited by
- Internal regulation between constitutively expressed T cell co-inhibitory receptors BTLA and CD5 and tolerance in recent thymic emigrants.
Adegoke AO, Thangavelu G, Chou TF, Petersen MI, Kakugawa K, May JF, Joannou K, Wang Q, Ellestad KK, Boon L, Bretscher PA, Cheroutre H, Kronenberg M, Baldwin TA, Anderson CC. Adegoke AO, et al. Open Biol. 2024 Oct;14(10):240178. doi: 10.1098/rsob.240178. Epub 2024 Oct 30. Open Biol. 2024. PMID: 39471840 Free PMC article. - Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies.
Pitts SC, Schlom J, Donahue RN. Pitts SC, et al. J Exp Clin Cancer Res. 2024 May 31;43(1):155. doi: 10.1186/s13046-024-03074-z. J Exp Clin Cancer Res. 2024. PMID: 38822401 Free PMC article. Review. - THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA.
Mélique S, Vadel A, Rouquié N, Yang C, Bories C, Cotineau C, Saoudi A, Fazilleau N, Lesourne R. Mélique S, et al. Proc Natl Acad Sci U S A. 2024 May 14;121(20):e2318773121. doi: 10.1073/pnas.2318773121. Epub 2024 May 7. Proc Natl Acad Sci U S A. 2024. PMID: 38713628 Free PMC article. - BTLA biology in cancer: from bench discoveries to clinical potentials.
Andrzejczak A, Karabon L. Andrzejczak A, et al. Biomark Res. 2024 Jan 17;12(1):8. doi: 10.1186/s40364-024-00556-2. Biomark Res. 2024. PMID: 38233898 Free PMC article. Review. - Microbiota-dependent regulation of costimulatory and coinhibitory pathways via innate immune sensors and implications for immunotherapy.
Park JS, Gazzaniga FS, Kasper DL, Sharpe AH. Park JS, et al. Exp Mol Med. 2023 Sep;55(9):1913-1921. doi: 10.1038/s12276-023-01075-0. Epub 2023 Sep 11. Exp Mol Med. 2023. PMID: 37696895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous